Analyses of inhibitory effects induced by the loss-of-function mutant integrin cellular functions
Analyses of inhibitory effects induced by the loss-of-function mutant integrin cellular functions
批准号:
14570979
负责人:
HONDA Shigenori
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
整合素αvβ3在血管和肿瘤组织中表达,包括内皮细胞、平滑肌细胞和癌细胞。αvβ3现在被认为在血管生成、肿瘤增殖和转移中起关键作用。本研究的主要目的是新发现蛋白素αvβ3 αv亚基上的配体结合位点,并阐明功能缺失αvβ3突变体对细胞功能的抑制作用机制。αvβ3 αv亚基的配体结合位点鉴定:为了评估αv RGD-contact环(Arg143-Phe154, Gly172-Gly18I, Asn2O6-Leu222)中每个残基的功能意义,我们进行了丙氨酸扫描诱变。将每个突变体αv与WT β3瞬时共转染到293T细胞中,利用WOW-1 Fab (αvβ3特异性的单价拟配单抗)和纤维蛋白原,流式细胞术检测突变体的配体结合功能。与晶体学分析一致,αv中的asp2I8Ala和Tyr178Ala消除了WOW-1 Fab和纤维蛋白原的结合。相反,αv中的Asp15OAla不影响配体结合功能。有趣的是,αv中的Ala215Tyr和Ala215Phe增加了配体结合。此外,tyr178phea αv没有干扰配体结合,这表明Tyr的芳香结构,而不是羟基侧链对配体结合(阳离子-π相互作用)至关重要。功能缺失突变体整合素对细胞功能的抑制作用分析:在表达αvβ3的293T细胞上过表达Tyr178Alaαvβ3 (αvβ3-293T)可抑制转染物对固定化纤维蛋白原的粘附,而转染细胞中内源性αvβ3的表面表达不降低。这些数据表明,过表达Tyr178Alaαvβ3可能对内源性αvβ3的功能产生显性的负作用。为了研究显性负作用的机制,我们构建了嵌合整合素,将整合素αv和β3的细胞外结构域替换为CD25的相应区域。在αv - β3- 293t细胞中过表达CD25/αv、CD25/β3嵌合体对固定纤维蛋白原的粘附均有抑制作用,而转染等量模拟DNA的细胞对固定纤维蛋白原的粘附无抑制作用。与转染CD25/αv相比,转染CD25/β3对细胞粘附的抑制作用更强。因此,这些数据表明Tyr178Alaαvβ3诱导的显性负作用可能与这两个亚基的细胞质结构域有关。少
英文摘要
Integrin αvβ3 is expressed in vascular and tumor tissues including endotherial cells, smooth muscle cells, and cancer cells. αvβ3 is now thought to play a key role in angiogenesis, tumor proliferation and metastasis. The primary goals of our study are to newly identify the ligand-binding sites on the αv subunit ofintegrin αvβ3, and elucidate the mechanisms of inhibitory effects induced by the loss-of-function αvβ3 mutant on cellular functions.Identification of the ligand-binding sites in the αv subunit of αvβ3: To evaluate functional significance of each residue within the RGD-contact loops of αv (Arg143-Phe154, Gly172-Gly18I, Asn2O6-Leu222) defined by crystallography, we have performed alanine-scanning mutagenesis. Each mutant αv was transiently co-transfected with WT β3 into 293T cells, and then the ligand-binding function of the mutants was assessed in flow cytometry employing WOW-1 Fab (a monovalent ligand-mimetic mAb specific for αvβ3) and fibrinogen. In agreement with crystallogr … More aphic analysis, asp2I8Ala as well as Tyr178Ala in αv abolished WOW-1 Fab and fibrinogen bindings. In contrast, Asp15OAla in αv did not impair the ligand-binding function. Interestingly, Ala215Tyr and Ala215Phe in αv increased ligand binding. Furthermore, Tyr178Pheαv did no disturb ligand binding, suggesting that aromatic structure of Tyr, rather than hydroxylic side chain is critical for ligand binding (cation-π interaction).Analyses of inhibitory effects induced by the loss-of-function mutant integrin on cellular functions: Overexpression of Tyr178Alaαvβ3 on 293T cells expressing αvβ3 (αvβ3-293T) inhibited the adhesion of the transfectants to immobilized fibrinogen, while the surface expression of endogenous αvβ3 was not decreased in the transfected cells. The data suggest that overexpression of Tyr178Alaαvβ3 may induce a dominant negative effect toward the function of endogenous αvβ3. To investigate a mechanism of the dominant negative effect, we constructed chimeric integrins in which the extracellular domains of integrins αv and β3 were replaced with the corresponding region of CD25. Overexpression of each chimera (CD25/αv, CD25/β3) into αvβ3-293T cells showed the inhibitory effects on the cell adhesion to immobilized fibrinogen, but the cells transfected with the same amount of mock DNA did not. The suppression of cell adhesion was more potent in the cells transfected with CD25/β3 as compared with CD25/αv. Thus, the data suggest that the dominant negative effect induced by Tyr178Alaαvβ3 may be associated with the cytoplasmic domains of both subunits. Less
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
H.Kashiwagi, M.Shiraga, S.Honda, et al.: "Activation of integrin αIIbβ3 in the glycoprotein Ib-high population of a megakaryocytic cell line, CMK, by inside-out signaling"J Thromb Haemost. 2(1). 177-186 (2004)
H.Kashiwagi、M.Shiraga、S.Honda 等人:“通过由内而外的信号传导,激活巨核细胞系 CMK 糖蛋白 Ib 高群体中的整合素 αIIbβ3”J Thromb Haemost。 .177-186 (2004)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Kashiwagi, M.Shiraga, S.Honda, et al.: "Activation of integrin αIIbβ3 in the glycoprotein lb-high population of a megakaryocytic cell line, CMK, by inside-out signaling"J Thromb Haemost. 2(1). 177-186 (2004)
H.Kashiwagi、M.Shiraga、S.Honda 等人:“巨核细胞系 CMK 糖蛋白 1b 高群体中整合素 αIIbβ3 通过由内而外的信号激活”J Thromb Haemost。 .177-186 (2004)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tadokoro S, Tomiyama Y, Honda S, et al.: "Missense mutations in the β3 subunit have a different impact on the expression and function between αIIbβ3 and αVβ3"Blood. 99(3). 931-938 (2002)
Tadokoro S、Tomiyama Y、Honda S 等人:“β3 亚基中的错义突变对 αIIbβ3 和 αVβ3 之间的表达和功能有不同的影响”Blood 99(3)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Kiyoi, Y.Tomiyama, S.Honda, et al.: "A naturally occurring Tyr143His αIIb mutation abolishes αIIbβ3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction : comparison with other mutations causing ligand-bin
T.Kiyoi、Y.Tomiyama、S.Honda 等人:“天然存在的 Tyr143His αIIb 突变废除了可溶性配体的 αIIbβ3 功能,但保留了其介导细胞粘附和凝块收缩的能力:与导致配体箱的其他突变进行比较
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Kiyoi, Y.Torniyama, S.Honda, et al.: "A naturally occurring Tyr143His αIIb mutation abolishes αIIbβ3 function for soluble ligands but retains its ability for mediating cell adhesion and clot retraction: comparison with-other mutations causing ligand-bin
T.Kiyoi、Y.Torniyama、S.Honda 等人:“天然存在的 Tyr143His αIIb 突变废除了可溶性配体的 αIIbβ3 功能,但保留了其介导细胞粘附和凝块收缩的能力:与导致配体箱的其他突变进行比较
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Elucidation of the role of ILK in the functional expression of beta3 integrins and investigation of the ILK-related molecules
-
批准号:23591430
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2011
-
负责人:HONDA Shigenori
-
依托单位:
Cloning and analysis of molecules involved in functional regulation of β3 integrin
-
批准号:20591162
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:HONDA Shigenori
-
依托单位:
Identification of signaling molecules associated with β3 integrins using random mutagenesis
-
批准号:18591095
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.49万
-
财政年份:2006
-
负责人:HONDA Shigenori
-
依托单位:
Structural and functional analyzes of integrin αvβ3 : identification of ligand-binding sites in the αv subunit of αvβ3 and development of inhibitor for αvβ3
-
批准号:12670989
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2000
-
负责人:HONDA Shigenori
-
依托单位:
Mechanisms of autoantibody-mediated pathological thrombosis in the mouse model with antiphospholipid symdrome
-
批准号:10670950
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:1998
-
负责人:HONDA Shigenori
-
依托单位:
国内基金
海外基金
登录
查看更多内容
血清 4 型禽腺病毒五邻体蛋白与整合素αVβ3互作介导病毒入侵的分子机制研究
-
批准号:ZCLQN26C1802
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王婷
-
依托单位:
αvβ3整合素靶向有机探针用于NIR-II FL/MRI双模态成像引导的三阴性乳腺癌光热治疗研究
-
批准号:2025JJ81013
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘芬
-
依托单位:
V3+/Cr4+/Mn5+激活的NIR-II发光材料的结构设计、价态稳定及性能优化研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:张丹
-
依托单位:
高熵掺杂驱动Zn3V3O8@CNTs电极晶格-界面协同重构及储锌机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于靶向整合素αvβ3的MPI/PET多模态成像技术在NASH早期纤维化中的可视化诊疗研究
-
批准号:82372144
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:邵拓
-
依托单位:
整合素αVβ3介导USC-Exos在股骨头坏死区域的富集机制及疗效研究
-
批准号:2023JJ30872
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:杜威
-
依托单位:
ANGPTL3通过整合素αVβ3促进巨噬细胞炎性功能加重动脉粥样硬化的机制
-
批准号:82370826
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:冯英梅
-
依托单位:
细胞外基质通过整合素αvβ3调控GSDMD介导的细胞焦亡通路在原始卵泡激活中的作用和机制研究
-
批准号:82301849
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:吴桐
-
依托单位:
基于EGFR/αvβ3双靶点调控细胞外基质的载药纳米探针对胰腺癌精准诊疗研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:任帅
-
依托单位:
外泌体Integrin αvβ3调控肝星状细胞的活化促进结肠癌肝转移的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:赵磊
-
依托单位: